Lisocabtagene maraleucel in relapsed/refractory mantle cell lymphoma: Primary analysis of the mantle cell lymphoma cohort from TRANSCEND NHL 001, a phase I multicenter seamless design study Journal Article


Authors: Wang, M.; Siddiqi, T.; Gordon, L. I.; Kamdar, M.; Lunning, M.; Hirayama, A. V.; Abramson, J. S.; Arnason, J.; Ghosh, N.; Mehta, A.; Andreadis, C.; Solomon, S. R.; Kostic, A.; Dehner, C.; Espinola, R.; Peng, L.; Ogasawara, K.; Chattin, A.; Eliason, L.; Palomba, M. L.
Article Title: Lisocabtagene maraleucel in relapsed/refractory mantle cell lymphoma: Primary analysis of the mantle cell lymphoma cohort from TRANSCEND NHL 001, a phase I multicenter seamless design study
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 10
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-04-01
Start Page: 1146
End Page: 1157
Language: English
DOI: 10.1200/jco.23.02214
PROVIDER: EBSCOhost
PROVIDER: cinahl plus with full text
PUBMED: 38072625
PMCID: PMC11741176
DOI/URL:
Notes: Accession Number: 176268668 -- Entry Date: In Process -- Revision Date: 20240329 -- Publication Type: Journal Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: CINAHL Plus with Full Text
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba